Christopher Anzalone - Chief Executive Officer, Director at Arrowhead Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
ARWR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Christopher Anzalone - trading volume in the past year for Arrowhead Pharmaceuticals, Inc.

Holdings reported by Christopher Anzalone for Arrowhead Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.72M $122M $32.71 Jan 31, 2024 Direct
Stock Option (right to buy) 352K Jan 31, 2024 Direct Common Stock

Transactions reported by Christopher Anzalone for Arrowhead Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.